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Background: Uremic toxin, indoxyl sulfate (IS), may impair
proliferation and function of endothelial cells (ET) aswell as endothelial
progenitor cells (EPC). Nicotinic acid (niacin), a lipid-lowering drug, has
antioxidant effect. Methods & results: EPC were isolated from healthy
subjects and incubated with 1 mM IS. IS decreased the viability of EPC
by 34%, andwas restored by 1 mMniacin. IS did not induce apoptosis of
EPC, but increased autophage and senescence of EPC, which were all
restored by adding niacin. The ability ofmigration and tube formation of
EPC were 50% inhibited by IS. Niacin restored the migration of EPC by
40%, but not tube formation. IS signiﬁcantly increased ROS and heme
oxygenase-1 expression, and decreased the expression of eNOS and
VEGF. All these adverse effects of IS were antagonized by niacin.
Conclusion: Niacin had beneﬁcial effects on ET in uremic patients, in
addition to lipid-lowering effect, through its restoration of EPC function.
doi:10.1016/j.lfs.2013.12.135
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ET-1 and inﬂammation are involved in the pathogenesis of
hypertension. Macrophages, which are recruited to the inﬂamed
vasculature, express both endothelin-A and endothelin-B receptors.
Macrophages can also produce and release ET-1 but the precise effects of
ET-1 on macrophage phenotype are unclear. Bone marrow derived
macrophages (prepared from C57/BL6 mice) were stimulated for 24 h
with ET-1 (10–1000 pg/ml), LPS/INFγ (100 ng/ml and 10 ng/ml) and
IL4/IL13 (10 ng/ml). Cytokines (TNFα, IL 6 and IL 10) and ET-1 were
measured by ELISA and qRT-PCR and mRNA for iNOS, MCP-1, mannose
receptor and Arginase 1 by qRT-PCR. Whereas LPS/INFγ increased
production of TNFα, IL6 and IL10 and upregulated markers of classical
activation (iNOS and MCP-1) ET-1 did not. IL4/IL13 stimulation
upregulated markers of alternative activation (mannose receptor and
arginase 1) but ET-1 did not. In addition, ET-1 pre-treatment and co-
stimulation did not affect the response to LPS. In vitro ET-1 does not
activate macrophages to alter phenotype and also does not have a co-
stimulating effect with factors known to stimulate classical or alternative
activation. This suggests that ET-1 is not pro-inﬂammatory to macro-
phages and does not induce an alternative activation.
N= 4 repeated in triplicate, ⁎P b 0.001 compared to untreated control.
doi:10.1016/j.lfs.2013.12.136
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Background: Endothelin (ET) system plays a critical role in the
development of insulin resistance and type 2 diabetes. However, the
molecularmechanism for ET receptor (ETR) signaling activated by ET-1
in skeletal muscle remains to be determined. The purpose of this study
was to determine the signaling molecules involved in ET-1-stimulated
phosphorylation of extracellular signal-regulated kinases 1 and 2
(ERK1/2) in rat skeletal muscle (L6) cells. Methods: Change in the
phosphorylation level of ERK1/2 was analyzed by Western blot
experiment. Dominant negative dynamin (K44A) along with mono-
meric strawberry redﬂuorescent protein (RFP)was overexpressed in L6
cells using adenovirus-mediated gene transfer. Infection efﬁciency of
the adenovirus was determined by ﬂuorescence of RFP with ﬂow
cytometry. Results: ET-1 induced concentration-dependent phosphor-
ylation of ERK1/2 in L6 cells. The phosphorylation of ERK1/2 was
abolished by BQ-123 (a selective ETAR antagonist), YM-254890 (aGαq/
11 protein inhibitor), PD98059 (a mitogen-activated protein kinase/
ERK kinase 1/2 inhibitor), and AG370 (a platelet-derived growth factor
receptor (PDGFR) kinase inhibitor). The ERK1/2 phosphorylation in
response to ET-1was inhibited by overexpression of dominant negative
dynamin (K44A), which blocks clathrin-mediated endocytosis of cell
surface receptor. Conclusions: Gq/11 protein-coupled ETAR is involved
in the ET-1-induced phosphorylation of ERK1/2 in L6 cells. The ETAR-
mediated phosphorylation of ERK1/2 is dependent on transactivation of
PDGFR, which requires dynamin-dependent receptor internalization.
doi:10.1016/j.lfs.2013.12.137
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The current paradigm of G protein coupled receptor (GPCR)
signalling involves transactivation of protein tyrosine kinase receptors.
We utilised human vascular smoothmuscle cells (VSMC) to address the
question if a GPCR, the endothelin receptor, could transactivate a serine/
threonine kinase receptor, speciﬁcally the TGF-β receptor, TβRI.
Signalling molecules were assessed by Western blotting and proteo-
glycan synthesis by 35S-sulphate and 35S-Met/Cys incorporation and
molecular size by SDS-PAGE. Endothelin-1 treatment led to a time and
concentration dependent increase in cytosolic phosphoSmad2C which
was blocked by themixed endothelin receptor antagonist bosentan and
the TβRI antagonist SB431542. Endothelin-1 treatment led to a time-
dependent increase in nuclear phosphoSmad2C. Endothelin-1 stimu-
lated proteoglycan synthesis was partially blocked by SB431542 and
completely inhibited by bosentan. The effect of endothelin to stimulate
an increase in glycosaminoglycan size on biglycanwas also blocked in a
concentration-dependent manner by SB431542. These data extend the
current paradigm of GPCR signalling to include the transactivation of
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